Infliximab treatment in a case of rheumatoid scleromalacia perforans

Abstract Views: 1138
PDF: 927
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Rheumatoid disease can cause ocular inflammation of the conjunctiva, sclera, and uveal tract. The sclera is an avascular layer covered by the episclera that is highly vascularised and can be affected by inflammation. Frequently, ophthalmic involvement in rheumatoid arthritis (RA) and spondyloartrhophaties results of a systemic and chronic inflammation that can produce devastating effects. Clinically, episcleritis looks similar to conjunctivitis, although there is no discharge. A common symptom of episcleritis is redness, and patients may also complain of foreign body...

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Herrera-Esparza, R., & Avalos-Diaz, E. (2009). Infliximab treatment in a case of rheumatoid scleromalacia perforans. Reumatismo, 61(3), 212–215. https://doi.org/10.4081/reumatismo.2009.212